{"id":38095,"date":"2022-11-05T13:30:24","date_gmt":"2022-11-05T13:30:24","guid":{"rendered":"https:\/\/positivelysharing.org\/blog\/?p=38095"},"modified":"2022-11-05T13:30:24","modified_gmt":"2022-11-05T13:30:24","slug":"after-viral-rebound-dolutegravir-based-treatment-more-likely-to-suppress-hiv","status":"publish","type":"post","link":"https:\/\/positivelysharing.org\/blog\/2022\/11\/05\/after-viral-rebound-dolutegravir-based-treatment-more-likely-to-suppress-hiv\/","title":{"rendered":"After viral rebound, dolutegravir-based treatment more likely to suppress HIV"},"content":{"rendered":"<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span><p><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-37031\" src=\"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2022\/09\/HIV-1-1-300x173.jpg\" alt=\"\" width=\"300\" height=\"173\" srcset=\"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2022\/09\/HIV-1-1-300x173.jpg 300w, https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2022\/09\/HIV-1-1-770x444.jpg 770w, https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2022\/09\/HIV-1-1-360x208.jpg 360w, https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2022\/09\/HIV-1-1.jpg 1024w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>Dolutegravir-based treatment is significantly more likely to result in re-suppression of HIV after viral rebound than treatment containing efavirenz, <a href=\"https:\/\/www.aidsmap.com\/news\/oct-2022\/after-viral-rebound-dolutegravir-based-treatment-more-likely-suppress-hiv\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span>Dolutegravir-based treatment is significantly more likely to result in re-suppression of HIV after viral rebound than treatment containing efavirenz, Read More<\/p>\n","protected":false},"author":1,"featured_media":25248,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[159],"tags":[],"class_list":{"0":"post-38095","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-hiv-2"},"jetpack_featured_media_url":"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/10\/Dolutegravir.jpg","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/38095","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/comments?post=38095"}],"version-history":[{"count":1,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/38095\/revisions"}],"predecessor-version":[{"id":38096,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/38095\/revisions\/38096"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media\/25248"}],"wp:attachment":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media?parent=38095"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/categories?post=38095"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/tags?post=38095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}